Search research articles
Contact Us
Filters
Showing results (101-110 of 627) with videos related to
Page
of 63
Sort By:
Journal of the American College of Cardiology
|
October 30, 2020
Effects of Canagliflozin on Amino-Terminal Pro-B-Type Natriuretic Peptide: Implications for Cardiovascular Risk Reduction
James L Januzzi, Jialin Xu, JingWei Li, et al.
American Heart Journal
|
March 30, 2006
Concerning the mechanism of pexelizumab's benefit in acute myocardial infarction
Paul W Armstrong, Kenneth W Mahaffey, Wei-Ching Chang, et al.
Clinical Cardiology
|
August 12, 2018
Association of Healthcare Plan with atrial fibrillation prescription patterns
Andrew Young Chang, Mariam Askari, Jun Fan, et al.
Coronary Artery Disease
|
January 6, 2012
Prediction of enzymatic infarct size in ST-segment elevation myocardial infarction
James S Mills, Kenneth W Mahaffey, Yuliya Lokhnygina, et al.
Journal of the American College of Cardiology
|
February 4, 2022
Stress Cardiac Biomarkers, Cardiovascular and Renal Outcomes, and Response to Canagliflozin
Muthiah Vaduganathan, Naveed Sattar, Jialin Xu, et al.
American Heart Journal
|
November 2, 2013
Prognostic implications of left ventricular end-diastolic pressure during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: Findings from the Assessment of Pexelizumab in Acute Myocardial Infarction study
Akshay Bagai, Paul W Armstrong, Amanda Stebbins, et al.
Endocrinology, Diabetes & Metabolism
|
July 19, 2021
Canagliflozin, serum magnesium and cardiovascular outcomes-Analysis from the CANVAS Program
Katherine M Wang, JingWei Li, Vivek Bhalla, et al.
American Journal of Nephrology
|
January 11, 2022
Clinical Utility of KidneyIntelX in Early Stages of Diabetic Kidney Disease in the CANVAS Trial
David Lam, Girish N Nadkarni, Gohar Mosoyan, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
May 26, 2009
Influence of body mass index on the efficacy of revascularization in patients with coronary artery disease
Aslan T Turer, Kenneth W Mahaffey, Emily Honeycutt, et al.
American Heart Journal
|
July 31, 2013
Rationale, design, and baseline characteristics of the Canagliflozin Cardiovascular Assessment Study (CANVAS)--a randomized placebo-controlled trial
Bruce Neal, Vlado Perkovic, Dick de Zeeuw, et al.
Page
of 63
Search research articles
Search
Showing results (101-110 of 627) with videos related to
Sort By:
Page
of 63
Journal of the American College of Cardiology
|
October 30, 2020
Effects of Canagliflozin on Amino-Terminal Pro-B-Type Natriuretic Peptide: Implications for Cardiovascular Risk Reduction
James L Januzzi, Jialin Xu, JingWei Li, et al.
American Heart Journal
|
March 30, 2006
Concerning the mechanism of pexelizumab's benefit in acute myocardial infarction
Paul W Armstrong, Kenneth W Mahaffey, Wei-Ching Chang, et al.
Clinical Cardiology
|
August 12, 2018
Association of Healthcare Plan with atrial fibrillation prescription patterns
Andrew Young Chang, Mariam Askari, Jun Fan, et al.
Coronary Artery Disease
|
January 6, 2012
Prediction of enzymatic infarct size in ST-segment elevation myocardial infarction
James S Mills, Kenneth W Mahaffey, Yuliya Lokhnygina, et al.
Journal of the American College of Cardiology
|
February 4, 2022
Stress Cardiac Biomarkers, Cardiovascular and Renal Outcomes, and Response to Canagliflozin
Muthiah Vaduganathan, Naveed Sattar, Jialin Xu, et al.
American Heart Journal
|
November 2, 2013
Prognostic implications of left ventricular end-diastolic pressure during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: Findings from the Assessment of Pexelizumab in Acute Myocardial Infarction study
Akshay Bagai, Paul W Armstrong, Amanda Stebbins, et al.
Endocrinology, Diabetes & Metabolism
|
July 19, 2021
Canagliflozin, serum magnesium and cardiovascular outcomes-Analysis from the CANVAS Program
Katherine M Wang, JingWei Li, Vivek Bhalla, et al.
American Journal of Nephrology
|
January 11, 2022
Clinical Utility of KidneyIntelX in Early Stages of Diabetic Kidney Disease in the CANVAS Trial
David Lam, Girish N Nadkarni, Gohar Mosoyan, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
May 26, 2009
Influence of body mass index on the efficacy of revascularization in patients with coronary artery disease
Aslan T Turer, Kenneth W Mahaffey, Emily Honeycutt, et al.
American Heart Journal
|
July 31, 2013
Rationale, design, and baseline characteristics of the Canagliflozin Cardiovascular Assessment Study (CANVAS)--a randomized placebo-controlled trial
Bruce Neal, Vlado Perkovic, Dick de Zeeuw, et al.
Page
of 63